Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic variants in C5 and poor response to eculizumab.
Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Brodsky AL, Noji H, Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama H, Hase M, Li L, Johnson K, Lazarowski A, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y. Nishimura J, et al. Among authors: brodsky al. N Engl J Med. 2014 Feb 13;370(7):632-9. doi: 10.1056/NEJMoa1311084. N Engl J Med. 2014. PMID: 24521109 Free article.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Kulasekararaj AG, Griffin M, Langemeijer S, Usuki K, Kulagin A, Ogawa M, Yu J, Mujeebuddin A, Nishimura JI, Lee JW, Peffault de Latour R; 301/302 Study Group. Kulasekararaj AG, et al. Eur J Haematol. 2022 Sep;109(3):205-214. doi: 10.1111/ejh.13783. Epub 2022 Jun 16. Eur J Haematol. 2022. PMID: 35502600 Free PMC article. Clinical Trial.
[Argentine Consensus in effective management of anticoagulation clinics for the use of vitamin k antagonists].
Ceresetto JM, Duboscq C, Korin J, Fondevila C, Casais P, Rossi A, Scazziota A, Martinuzzo M, Aris Cancela ME, Rosa C, Pombo G, Guimelli C, Adamczuk Y, Martí A, Penchasky D, Riveros D, Puente D, Celebrin L, Molnar S, Meschengieser S, Castro Ríos M, Blanco A, Hendler H, Brodsky A, Sánchez Luceros A, Negri Aranguren P, Fedele JL, Merlo C, Raña P, Gumpel C, Colorio C, Grand B, Canónico V, Rossi E, Colimodio P, Orlando S, Fassi D, Arias M, Viudez L, Farreras R, Martínez P, Ferro H, Casali C, Baques A, Arbesú G, Viñuales S, Medina F, Cortés V, Gallo MDC, Ehelou L, Barrera L, Rey I, de Larrañaga G, Figueroa F, Vilaseca A, Kuri I, Maneyro A, Otaran M, Xavier DL, Garbiero S, Salviú J, Fontenla P, Eckhardt A, Bomparola C, Fornasiero L. Ceresetto JM, et al. Medicina (B Aires). 2020;80 Suppl 4:1-26. Medicina (B Aires). 2020. PMID: 32897867 Free article. Spanish.
[MANAGEMENT RECOMMENDATIONS FOR DIRECT ORAL ANTICOAGULANTS (DOACs) ANTI Xa AND ANTI IIa].
Ceresetto JM, Tajer C, Duboscq C, Bottaro F, Casais P, Korin J, Fondevila C, Giumelli C, Scazziota A, Rossi A, Botto F, Ariscancela ME, Martinuzzo M, Zaidel E, Fitz Maurice M, Bahit C, Vazquez F, Molnar S, Saizberg S, Negri Aranguren P, Rosa C, Fedele JL, Comignani P, Pombo G, Raña P, Adamczuk Y, Martí A, Charask A, Penchasky D, Riveros D, Mariani J, Puente D, Celebrin L, Bosio M, Brodsky A, Sanchez Lucero A, Castillo Costa Y, Hirschson A, Arbesú G, Viñuales S, Kazelian L, Maneyro A, Gutierrez V, Castro Rios M, Gagliardi J, Lescano A, Repetto F. Ceresetto JM, et al. Medicina (B Aires). 2022 Mar;82 Suppl 2:1-55. Medicina (B Aires). 2022. PMID: 35344926 Free article. Spanish.
35 results